Institute of Behavioral Science
Finding solutions for the most difficult challenges in mental health
The Institute of Behavioral Science leads the nation in research into intervention and services for severe mental health disorders. This includes advancing new tools and strategies for patient engagement, monitoring, and clinical decision making for better care. A substantial portfolio of grants featuring federal government and private philanthropic funds support these standard-setting efforts. The institute runs a number of clinical trials not only to standardize outcome measurements in psychiatric research, but to ensure the translation of research into clinical practice.
The institute is known for pioneering new treatments for schizophrenia and first-episode psychosis. Its most recent breakthroughs in using neuroimaging and genetic markers for early identification and treatment of mental health disease—and its work in using social media data to generate early intervention strategies (particularly with young people)—are recognized as leading the nation in best practices.
At the heart of the institute is the Zucker Hillside Hospital, Northwell Health’s nationally recognized behavioral health center known for its pioneering clinical, teaching and research programs. The National Institute of Mental Health has established a Clinical Research Center for the Study of Schizophrenia at Zucker Hillside Hospital, one of only four such facilities nationwide.
View our Institute of Behavioral Science researchers.
1 in 100: Schizophrenia
Schizophrenia is a brain disease that affects one out of every 100 people in the world. Watch a video on Dr. John Kane, who has dedicated his life to researching this disease.